Sinohealth Holdings (HKSE:02361) ROCE % : 12.08% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sinohealth Holdings's annualized ROCE % for the quarter that ended in Jun. 2024 was 12.08%.

Sinohealth Holdings ROCE % Historical Data

The historical data trend for Sinohealth Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinohealth Holdings ROCE % Chart

Sinohealth Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

16.79

17.86

21.53

9.46

15.61

Sinohealth Holdings Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial				1.92	17.73	13.33	17.49	12.08

Sinohealth Holdings ROCE % Calculation

Sinohealth Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	121.826	/	( ( (889.433 - 109.202)	+	(872.552 - 92.163) )	/ 2 )
	=	121.826	/	( (780.231	+	780.389)	/ 2 )
	=	121.826	/	780.31
	=	15.61 %

Sinohealth Holdings's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	92.31	/	( ( (872.552 - 92.163)	+	(874.392 - 127.056) )	/ 2 )
	=	92.31	/	( ( 780.389	+	747.336 )	/ 2 )
	=	92.31	/	763.8625
	=	12.08 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Sinohealth Holdings (HKSE:02361) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sinohealth Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinohealth Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN

Website

https://ir.sinohealth.cn

Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.

Executives

Futu Trustee Limited	2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd	2201 Interest of corporation controlled by you
Yu Rong	2201 Interest of corporation controlled by you
Tianyi (bvi) Limited	2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang	2201 Interest of corporation controlled by you
Wu Yushu	2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited	2101 Beneficial owner
Li Hanxiong	2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd	2101 Beneficial owner
Wu Meirong	2202 Interest of your spouse
Ying Lian You Xian Gong Si	2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines